Certain types of hematologic cancer cells (e.g., acute myeloid leukemia cells) require BRD9 to sustain MYC transcription, cell proliferation, and a block in differentiation28. This evidence concerns the gene BRD9 and hematopoietic and lymphoid cell neoplasm.